Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-11-01FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole, Wal-Mart's store-brand lansoprazole. The approval confirms the Wal-Mart Sto…
-
FDA approval · 2022-10-04FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) from The Procter & Gamble Manufacturing Company, updating it…
-
FDA approval · 2022-09-30FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA granted a supplemental approval for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen.
-
FDA approval · 2022-09-16FDA Approved: DEXLANSOPRAZOLE DELAYED RELEASE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved a generic dexlansoprazole delayed-release tablet by Upsher-Smith Laboratories, LLC under an original ANDA.
-
FDA approval · 2022-09-14FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Rabeprazole sodium submitted by Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-09-14FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for rabeprazole sodium (Ascend Laboratories, LLC). This indicates regulatory approval of the generic…
-
FDA approval · 2022-09-06FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) from Haleon US Holdings LLC.
-
FDA approval · 2022-09-06FDA Approved: NEXIUM 24HR — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Nexium 24HR (esomeprazole magnesium) submitted by Haleon US Holdings LLC.
-
FDA approval · 2022-09-02FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for rabeprazole sodium submitted by Torrent Pharmaceuticals Limited.
-
FDA approval · 2022-08-29FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Northstar Rx LLC)
FDA approved Pantoprazole sodium as an original ANDA for a generic product manufactured by Northstar Rx LLC.
-
FDA approval · 2022-08-25FDA Approved: ZANTAC 360 — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for ZANTAC 360 (famotidine) submitted by Chattem, Inc., under ANDA206531.
-
FDA approval · 2022-08-15FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for pantoprazole filed by NorthStar RxLLC.
-
FDA approval · 2022-08-11FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited. The action is a supplemental approval,…
-
FDA approval · 2022-08-04FDA Approved: FAMOTIDINE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approves Amneal's original application for famotidine, enabling a generic version of the H2 blocker. The approval covers common indicati…
-
FDA approval · 2022-07-28FDA Approved: FAMOTIDINE — Supplemental Application (Akorn)
FDA approved a supplemental application for famotidine from Akorn (ANDA 201995). This approval confirms continued availability of this gener…
-
FDA approval · 2022-07-28FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for pantoprazole sodium from Eugia US LLC. The action pertains to an already approved generic, t…
-
FDA approval · 2022-07-28FDA Approved: CURIST ACID RELIEF — Supplemental Application (Little Pharma, Inc.)
FDA granted a supplemental approval for Curist Acid Relief containing famotidine 20 mg from Little Pharma, Inc., updating the ANDA with the …
-
FDA approval · 2022-07-26FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE — Original Application (Lifestar Pharma LLC)
FDA approved pantoprazole sodium delayed-release through an original application for Lifestar Pharma LLC.
-
FDA approval · 2022-06-24FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for esomeprazole magnesium as a generic proton pump inhibitor manufactured by Rising Pharma Holdings, Inc.
-
FDA approval · 2022-06-16FDA Approved: DEXLANSOPRAZOLE — Supplemental Application (ENDO USA, Inc.)
The FDA approved a supplemental application for dexlansoprazole submitted by ENDO USA, Inc.
-
FDA approval · 2022-06-09FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for pantoprazole sodium from Lannett Company, enabling the marketing of this generic proton pump inh…
-
FDA approval · 2022-06-09FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for pantoprazole sodium from NorthStar Rx LLC, a generic pantoprazole product.
-
FDA approval · 2022-06-03FDA Approved: FAMOTIDINE — Original Application (Zydus Lifesciences Limited)
The FDA approved an original abbreviated new drug application (ANDA) for famotidine from Zydus Lifesciences Limited, making a generic versio…
-
FDA approval · 2022-05-19FDA Approved: PANTOPRAZOLE SODIUM I.V. — Original Application (Piramal Critical Care)
FDA approved Pantoprazole sodium for injection (IV) from Piramal Critical Care under an original application.
-
FDA approval · 2022-05-18FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved Pantoprazole sodium from Novadoz Pharmaceuticals LLC under an Original Application (ANDA216171), adding a generic pantopraz…